En esta página
01NVNO precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
NVNO enVVeno Medical Corporation - Common Stock
NASDAQ · Health Care · Ver en SEC EDGAR ↗ 10-K/10-Q Jul 30, 2026
$6,65
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$6,57mínimo 52 semanas
$26,25máximo 52 semanas
Capitalización Bursátil (MRQ)
$4M
P/E
-0.2
BPA
$-33.06
tus insignias
Rango 52S
$7–$26
Calificación del Analista
STRONG BUY
Precio Objetivo
$30
P/E
-0.2
ROE
-64.7%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
NVNO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$6.65
Capitalización Bursátil (MRQ)
$4M
P/E
-0.2
BPA
$-33.06
ROE
-64.7%
Rango 52S
$7–$26
NVNO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 20 de enero de 2026 | 1-for-35 | Inversa |
| 30 de noviembre de 2020 | 1-for-25 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos·2017-12-31 → 2019-12-31
BPA$-33.062022-12-31 → 2025-12-31
Flujo de caja libre$-16M2018-12-31 → 2025-12-31
Margen neto·2018-12-31 → 2022-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | NVNO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -0.2promedio 5A ≈-1.3 | ≈-1.3 | · | · | |
| P/S | 23.3promedio 5A ≈226.8 | ≈226.8 | 1.6 | Infravalorado | |
| P/C (MRQ) | 0.2promedio 5A ≈1.0 | ≈1.0 | 1.2 | Infravalorado | |
| Price / FCF (Precio / FCF) | -0.3promedio 5A ≈-2.5 | ≈-2.5 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -0.3promedio 5A ≈-2.5 | ≈-2.5 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.2promedio 5A ≈1.0 | ≈1.0 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | NVNO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -52.3%promedio 5A ≈-50.2% | ≈-50.2% | -106.2% | De primer nivel | |
| ROE | -64.7%promedio 5A ≈-60.1% | ≈-60.1% | -270.9% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | NVNO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 11.7promedio 5A ≈23.6 | ≈23.6 | 3.3 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 13.3promedio 5A ≈23.3 | ≈23.3 | 1.6 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
9.9%
Próximo informe
Oct 28, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Jul 29, 2026 | $-5.37 | $-4.78 | -12.3% |
| 30 de septiembre de 2025 | $-8.05 | $-10.71 | 24.8% | |
| 30 de junio de 2025 | $-11.55 | $-10.00 | -15.5% | |
| 31 de marzo de 2025 | $-7.70 | $-12.14 | 36.6% | |
| 31 de diciembre de 2024 | $-10.50 | $-12.49 | 16.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $31.2K | $186.6K | $422.1K | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $419.7K | |
| Gross Profit | · | · | · | · | · | · | · | $186.6K | $2.5K | |
| R&D Expense | $10M | $12M | $14M | $10M | $6M | $4M | $2M | $1M | $649.7K | |
| SG&A Expense | $11M | $12M | $12M | $15M | $11M | $5M | $5M | $6M | $5M | |
| Operating Income | $-21M | $-24M | $-25M | $-25M | $-17M | $-9M | $-8M | $-8M | $-6M | |
| Other Non-op | $1M | $2M | $2M | $263.0K | $33.0K | $-215.9K | $-49.9K | $5M | $2M | |
| Pretax Income | $-19M | $-22M | · | · | · | · | · | · | · | |
| Net Income | $-19M | $-22M | $-24M | $-25M | $-17M | $-9M | $-8M | $-13M | $-8M | |
| EPS (Basic) | $-33.06 | $-44.53 | $-1.91 | $-2.20 | $-1.90 | · | · | · | · | |
| EPS (Diluted) | $-33.06 | $-44.53 | $-1.91 | $-2.20 | · | · | · | · | · | |
| Shares (Basic) | 589,000 | 490,000 | 12,301,000 | 11,230,000 | 8,680,000 | · | · | · | · | |
| Shares (Diluted) | 589,000 | 490,000 | 12,301,000 | 11,230,000 | · | · | · | · | · | |
| EBITDA | $-21M | $-24M | $-25M | $-25M | · | $-9M | $-8M | $-8M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $2M | $4M | $5M | $55M | $9M | $1M | $3M | $77.7K | |
| Short-term Investments | $25M | $41M | $43M | $34M | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | $32.0K | $35.2K | |
| Prepaid Expense | $614.0K | $581.0K | $511.0K | $392.0K | $312.0K | $234.5K | $116.6K | $64.3K | $57.5K | |
| Current Assets | $29M | $44M | $47M | $39M | $55M | $10M | $1M | $3M | $170.4K | |
| PP&E (Net) | $51.0K | $182.0K | $334.0K | $521.0K | $618.0K | $399.0K | $344.0K | $26.2K | $23.8K | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $1M | $886.9K | $737.1K | $373.2K | $386.8K | |
| Accum. Depreciation | $1M | $1M | $1M | $849.0K | $637.0K | $487.9K | $393.1K | $347.1K | $362.9K | |
| Intangibles | · | · | · | · | · | · | · | $666.5K | $1M | |
| Total Assets | $30M | $45M | $49M | $42M | $58M | $11M | $3M | $4M | $2M | |
| Accounts Payable | $358.0K | $1M | $1M | $1M | $560.0K | $1M | $1M | $1M | $1M | |
| Accrued Liabilities | · | · | · | · | · | $1M | $333.4K | $412.9K | $903.6K | |
| Short-term Debt | · | · | · | · | · | $312.7K | · | · | $275.0K | |
| Current Liabilities | $2M | $2M | $1M | $2M | $2M | $3M | $2M | $2M | · | |
| Capital Leases | $310.0K | $700.0K | $1M | $1M | $2M | $253.7K | $567.9K | · | · | |
| Total Liabilities | $2M | $3M | $2M | $3M | $3M | $3M | $2M | $2M | $8M | |
| Total Debt | · | · | · | · | · | $312.7K | · | · | · | |
| Common Stock | · | · | · | · | · | $25 | $7 | $117 | $61 | |
| Paid-in Capital | $198M | $194M | $176M | $145M | $136M | $72M | $57M | $51M | $24M | |
| Retained Earnings | $-171M | $-152M | $-130M | $-107M | $-82M | $-65M | $-56M | $-49M | $-36M | |
| Stockholders' Equity | $27M | $42M | $46M | $39M | $54M | $7M | $989.9K | $2M | $-11M | |
| Liabilities + Equity | $30M | $45M | $49M | $42M | $58M | $11M | $3M | $4M | $2M | |
| Shares Outstanding | 656,000 | 501,000 | 13,317,000 | 9,472,000 | 9,470,000 | 2,541,529 | 717,274 | 11,722,647 | 6,133,678 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $136.0K | $189.0K | $220.0K | $212.0K | $149.0K | $97.5K | $123.7K | $133.4K | $139.2K | |
| Stock-based Comp | $3M | $4M | $5M | $9M | $6M | $881.2K | $942.0K | $2M | $878.4K | |
| Amort. of Intangibles | · | · | · | · | · | · | $77.6K | $111.9K | $123.3K | |
| Operating Cash Flow | $-16M | $-17M | $-19M | $-16M | $-12M | $-8M | $-6M | $-6M | $-4M | |
| CapEx | $5.0K | $37.0K | $33.0K | $115.0K | $368.0K | $180.3K | $363.9K | $12.4K | $10.9K | |
| Investing Cash Flow | $16M | $1M | $-8M | $-35M | $-368.0K | $-180.3K | $-363.9K | $-12.4K | $165.3K | |
| Stock Issued | $782.0K | · | $26M | · | $57M | $12M | · | · | · | |
| Net Stock Activity | $782.0K | · | $26M | · | · | · | · | · | · | |
| Financing Cash Flow | $1M | $14M | $26M | · | $58M | $15M | $6M | $9M | $4M | |
| Net Change in Cash | $1M | $-2M | $-935.0K | $-50M | $45M | $7M | $-623.4K | $3M | $21.2K | |
| Free Cash Flow | $-16M | $-17M | $-19M | $-16M | · | $-8M | $-6M | $-6M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 100.0% | · | |
| Operating Margin | · | · | · | -15485.7% | · | 244320.0% | -24566.5% | -4210.5% | · | |
| Net Margin | · | · | · | -15322.4% | · | 244329.7% | -24406.7% | -6991.5% | · | |
| EBITDA Margin | · | · | · | -15485.7% | · | 244320.0% | -24566.5% | -4210.5% | · | |
| ROA | -52.3% | -46.6% | -52.1% | -49.7% | · | -130.8% | -218.1% | -451.8% | · | |
| ROE | -64.7% | -48.7% | -66.1% | -60.6% | · | -153.6% | -374.4% | -467.6% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.6 | 20.9 | 34.2 | 25.8 | · | 3.0 | 0.8 | · | · | |
| Quick Ratio | 13.3 | 20.6 | 33.9 | 25.5 | · | 2.9 | 0.7 | · | · | |
| Debt / Equity | · | · | · | · | · | 0.0 | · | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | · | -0.0 | 0.0 | 0.1 | · | |
| Receivables Turnover | · | · | · | · | · | · | · | 5.6 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $41.36 | $2.40 | $3.47 | $4.09 | · | $2.79 | $0.06 | $0.17 | · | |
| Cash Flow / Share | $-26.43 | $-0.98 | $-1.53 | · | · | · | · | · | · | |
| Cash / Share | $4.67 | $0.10 | $0.27 | $0.48 | · | $3.67 | $0.07 | $0.23 | · | |
| EPS (TTM) | $-33.06 | $-44.53 | $-1.91 | $-2.20 | · | · | · | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | 747.4% | 408.2% | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $187.3K | $187.3K | $187.3K | $187.3K | $187.3K | $187.3K | $31.2K | $186.6K | · | |
| Net Income TTM | $-19M | $-22M | $-24M | $-25M | $-17M | $-9M | $-8M | $-13M | · | |
| Market Cap | $210.6K | $53M | $68M | $48M | · | $22M | $247M | $432M | · | |
| Enterprise Value | · | · | · | · | · | $13M | · | · | · | |
| P/E | -0.0 | -0.1 | -2.7 | -2.3 | · | · | · | · | · | |
| P/S | 1.1 | 282.7 | 365.4 | 257.9 | · | 117.4 | 7891.8 | 2317.2 | · | |
| P/B | 0.0 | 1.3 | 1.5 | 1.2 | · | 3.1 | 249.1 | 212.3 | · | |
| P / Tangible Book | 0.0 | 1.3 | 1.5 | 1.2 | 1.1 | 3.1 | · | · | · | |
| P / Cash Flow | -0.0 | -3.1 | -3.6 | -3.1 | · | -2.9 | -41.8 | -68.0 | · | |
| P / FCF | -0.0 | -3.1 | -3.6 | -3.1 | · | -2.8 | -39.4 | -67.9 | · | |
| EV / EBITDA | · | · | · | · | · | -1.4 | · | · | · | |
| EV / FCF | · | · | · | · | · | -1.6 | · | · | · | |
| EV / Revenue | · | · | · | · | · | 69.2 | · | · | · | |
| Earnings Yield | -10299.1% | -1474.5% | -37.2% | -43.1% | · | · | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $4M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | |
| Operating Income | $-4M | $-4M | $-4M | $-5M | $-7M | $-5M | $-7M | $-6M | $-5M | $-6M | $-6M | $-5M | $-7M | $-7M | $-6M | $-6M | |
| Other Non-op | $196.0K | $213.0K | $277.0K | $344.0K | $355.0K | $451.0K | $470.0K | $528.0K | $498.0K | $511.0K | $629.0K | $348.0K | $340.0K | $405.0K | $280.0K | $54.0K | |
| Net Income | $-4M | $-4M | $-4M | $-5M | $-7M | $-5M | $-6M | $-6M | $-5M | $-5M | $-6M | $-5M | $-6M | $-6M | $-6M | $-6M | |
| EPS (Basic) | $-5.37 | $-5.89 | $-32.28 | $-0.23 | $-11.52 | $-7.75 | $-43.56 | $-0.35 | $-0.31 | $-0.31 | $-0.31 | $-0.45 | $-0.58 | $-0.57 | $-0.56 | $-0.54 | |
| EPS (Diluted) | $-5.37 | $-5.89 | $-32.28 | $-0.23 | $-11.52 | $-7.75 | $-43.56 | $-0.35 | $-0.31 | $-0.31 | $-0.31 | $-0.45 | $-0.58 | $-0.57 | $-0.55 | $-0.54 | |
| Shares (Basic) | 671,000 | 654,000 | · | 20,155,000 | 581,000 | 581,000 | · | 16,067,000 | 16,067,000 | 16,057,000 | · | 11,231,000 | 11,231,000 | 11,231,000 | · | 11,229,000 | |
| Shares (Diluted) | 671,000 | 654,000 | · | 20,155,000 | 581,000 | 581,000 | · | 16,067,000 | 16,067,000 | 16,057,000 | · | 11,231,000 | 11,231,000 | 11,231,000 | · | 11,229,000 | |
| EBITDA | $-4M | $-4M | · | $-5M | $-7M | $-5M | · | $-6M | $-5M | $-6M | · | $-5M | $-7M | $-7M | · | $-6M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $18M | $2M | $2M | $4M | $5M | $5M | $2M | $5M | $3M | |
| Short-term Investments | $19M | $22M | $25M | $29M | $33M | $36M | $41M | $30M | $37M | $41M | $43M | $21M | $25M | $32M | $34M | $37M | |
| Prepaid Expense | $596.0K | $559.0K | $614.0K | $547.0K | $462.0K | $538.0K | $581.0K | $672.0K | $469.0K | $306.0K | $511.0K | $520.0K | $352.0K | $312.0K | $392.0K | $381.0K | |
| Current Assets | $22M | $25M | $29M | $31M | $36M | $39M | $44M | $49M | $40M | $43M | $47M | $26M | $30M | $35M | $39M | $41M | |
| PP&E (Net) | $78.0K | $16.0K | $51.0K | $82.0K | $113.0K | $142.0K | $182.0K | $218.0K | $252.0K | $289.0K | $334.0K | $385.0K | $438.0K | $472.0K | $521.0K | $566.0K | |
| PP&E (Gross) | · | · | $1M | · | · | $1M | $1M | · | · | $1M | $1M | · | · | $1M | $1M | · | |
| Accum. Depreciation | · | · | $1M | · | · | $1M | $1M | · | · | $1M | $1M | · | · | $903.0K | $849.0K | · | |
| Total Assets | $23M | $26M | $30M | $32M | $37M | $41M | $45M | $50M | $41M | $45M | $49M | $28M | $32M | $37M | $42M | $45M | |
| Accounts Payable | $540.0K | $813.0K | $358.0K | $2M | $3M | $1M | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $847.0K | $1M | $501.0K | |
| Current Liabilities | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | $2M | $1M | |
| Capital Leases | $103.0K | $207.0K | $310.0K | $505.0K | $505.0K | $609.0K | $700.0K | $791.0K | $882.0K | $973.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $2M | $2M | $2M | $3M | $4M | $2M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $2M | $3M | $3M | |
| Paid-in Capital | $199M | $199M | $198M | $197M | $196M | $195M | $194M | $193M | $178M | $177M | $176M | $149M | $148M | $147M | $145M | $143M | |
| Retained Earnings | $-179M | $-175M | $-171M | $-168M | $-163M | $-156M | $-152M | $-146M | $-140M | $-135M | $-130M | $-124M | $-119M | $-113M | $-107M | $-100M | |
| Stockholders' Equity | $21M | $24M | $27M | $29M | $33M | $38M | $42M | $47M | $38M | $42M | $46M | $25M | $29M | $34M | $39M | $43M | |
| Liabilities + Equity | $23M | $26M | $30M | $32M | $37M | $41M | $45M | $50M | $41M | $45M | $49M | $28M | $32M | $37M | $42M | $45M | |
| Shares Outstanding | 673,000 | 656,000 | 656,000 | 20,216,000 | 19,247,000 | 17,536,000 | 501,000 | 17,536,000 | 13,330,000 | 13,330,000 | 13,317,000 | 9,472,000 | 9,472,000 | 9,472,000 | 9,472,000 | 9,472,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $31.0K | $31.0K | $31.0K | $34.0K | $40.0K | $40.0K | $43.0K | $51.0K | $55.0K | $55.0K | $56.0K | $55.0K | $54.0K | $54.0K | $54.0K | |
| Stock-based Comp | $397.0K | $467.0K | $637.0K | $688.0K | $1M | $651.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| Operating Cash Flow | $-4M | $-3M | $-3M | $-4M | $-4M | $-4M | $-5M | $-4M | $-4M | $-4M | $-5M | $-4M | $-5M | $-5M | $-4M | $-4M | |
| CapEx | · | · | $0 | $0 | · | · | $4.0K | $9.0K | $14.0K | $10.0K | $4.0K | $3.0K | $21.0K | $5.0K | $9.0K | $14.0K | |
| Investing Cash Flow | $4M | $3M | $4M | $4M | $3M | $5M | $-11M | $6M | $4M | $2M | $-22M | $4M | $7M | $3M | $6M | $-2M | |
| Financing Cash Flow | · | · | $782.0K | · | · | · | $0 | $14M | $0 | $46.0K | · | · | · | · | · | · | |
| Net Change in Cash | $244.0K | $-468.0K | $2M | $-500.0K | $-893.0K | $1M | $-16M | $16M | $66.0K | $-1M | $-1M | $232.0K | $2M | $-2M | $2M | $-6M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-4M | · | · | · | $-5M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -12.2% | -11.6% | · | -11.0% | -17.3% | -10.5% | · | -14.4% | -13.6% | -12.3% | · | -13.6% | -15.8% | -14.1% | · | -11.7% | |
| ROE | -13.4% | -12.4% | · | -11.8% | -18.7% | -11.2% | · | -15.6% | -14.7% | -13.1% | · | -14.8% | -17.2% | -15.0% | · | -12.1% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.7 | 11.9 | · | 13.1 | 11.8 | 23.8 | · | 22.0 | 23.3 | 29.1 | · | 12.9 | 14.6 | 29.6 | · | 31.2 | |
| Quick Ratio | 11.4 | 11.6 | · | 12.9 | 11.7 | 23.4 | · | 21.7 | 23.0 | 28.9 | · | 12.7 | 14.4 | 29.3 | · | 30.9 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $30.71 | $36.20 | · | $1.46 | $1.72 | $2.18 | · | $2.70 | $2.88 | $3.18 | · | $2.63 | $3.04 | $3.60 | · | $4.50 | |
| Cash Flow / Share | · | $-4.95 | · | · | · | $-0.20 | · | · | · | $-0.22 | · | · | · | · | · | · | |
| Cash / Share | $4.22 | $3.96 | · | $0.08 | $0.11 | $0.17 | · | $1.02 | $0.18 | $0.17 | · | $0.52 | $0.50 | $0.24 | · | $0.31 | |
| EPS (TTM) | $-43.77 | $-49.92 | · | $-63.06 | $-63.18 | $-51.97 | · | $-1.28 | $-1.38 | $-1.65 | · | $-2.15 | $-2.24 | $-2.29 | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-16M | $-19M | · | $-22M | $-23M | $-21M | · | $-21M | $-21M | $-22M | · | $-24M | $-25M | $-26M | · | $-27M | |
| Market Cap | $7M | $7M | · | $18M | $77M | $46M | · | $59M | $70M | $73M | · | $51M | $29M | $44M | · | $59M | |
| P/E | -0.2 | -0.2 | · | -0.5 | -2.2 | -1.8 | · | -91.9 | -133.2 | -115.4 | · | -87.7 | -48.1 | -71.5 | · | · | |
| P/B | 0.3 | 0.3 | · | 0.6 | 2.3 | 1.2 | · | 1.2 | 1.8 | 1.7 | · | 2.0 | 1.0 | 1.3 | · | 1.4 | |
| P / Tangible Book | 0.3 | 0.3 | · | 0.6 | 2.3 | 1.2 | · | 1.2 | 1.8 | 1.7 | · | 2.0 | 1.0 | 1.3 | · | 1.4 | |
| P / Cash Flow | · | -2.1 | · | · | · | -11.5 | · | · | · | -20.4 | · | · | · | -8.7 | · | · | |
| Earnings Yield | -408.7% | -492.8% | · | -198.9% | -45.2% | -56.5% | · | -1.1% | -0.75% | -0.87% | · | -1.1% | -2.1% | -1.4% | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Margen Operativo % | · | · | · | -15485.7% | · |
| Beneficio neto | $-19M | $-22M | $-24M | $-25M | $-17M |
| EPS Diluido | $-33.06 | $-44.53 | $-1.91 | $-2.20 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 13.6 | 20.9 | 34.2 | 25.8 | · |
| Ratio Rápido | 13.3 | 20.6 | 33.9 | 25.5 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-16M | $-17M | $-19M | $-16M | · |
Propietarios institucionales (13F) 20 declarantes · $1.1M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
20
Valor en tenencia
$1.1M
Nuevas posiciones
2
Posiciones cerradas
3
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 2 | 3 | 0 | 6 | · |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado. Cambio vs trimestre anterior no mostrado: la cobertura de los presentadores difiere demasiado entre estos dos trimestres para una comparación fiable.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $387 338 | 36 166 | 36,16% | Acciones |
| CM Management, LLC | $382 497 | 35 714 | 35,71% | Acciones |
| VANGUARD GROUP INC | $96 058 | 299 246 | 8,97% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $67 397 | 6 287 | 6,29% | Acciones |
| JPMORGAN CHASE & CO | $59 111 | 5 208 | 5,52% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $23 412 | 2 184 | 2,19% | Acciones |
| WOLVERINE TRADING, LLC | $17 204 | 18 339 | 1,61% | Acciones |
| Westside Investment Management, Inc. | $16 332 | 1 525 | 1,52% | Acciones |
| Mirae Asset Global Investments Co., Ltd. | $5 773 | 539 | 0,54% | Acciones |
| TWO SIGMA ADVISERS, LP | $4 491 | 14 000 | 0,42% | Acciones |
| BlackRock, Inc. | $4 434 | 414 | 0,41% | Acciones |
| Tower Research Capital LLC (TRC) | $3 545 | 331 | 0,33% | Acciones |
| WELLS FARGO & COMPANY/MN | $1 221 | 114 | 0,11% | Acciones |
| Vanguard Global Advisers, LLC | $825 | 77 | 0,08% | Acciones |
| CIBC Private Wealth Group LLC | $779 | 860 | 0,07% | Acciones |
| MORGAN STANLEY | $632 | 59 | 0,06% | Acciones |
| OSAIC HOLDINGS, INC. | $74 | 7 | 0,01% | Acciones |
| BARCLAYS PLC | $21 | 2 | 0,00% | Acciones |
| GROUP ONE TRADING LLC | $21 | 2 | 0,00% | Acciones |
| UBS Group AG | $11 | 1 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Braeden Lichti, Northstrive Fund II LP ×2 presentaciones | 15 de septiembre de 2026 | 0,00% | Enmienda | · | SEC |
| Northstrive Fund II LP, Braeden Lichti | 20 de febrero de 2026 | 5,05% | Presentación inicial | Inversión pasiva | SEC |
| Fatboy Capital, LP, SeaCap Management, LLC, David A. Jenkins ×2 presentaciones | 18 de diciembre de 2020 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 12 insiders · 6 directivos · 6 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Robert Andrew Berman | Chief Executive Officer | 16 de diciembre de 2025 J | 222 236 | 0 | 0 | $0 |
| Jennifer Bright | Chief Financial Officer | 19 de mayo de 2025 A | · | 0 | 0 | $0 |
| Craig Glynn | Chief Financial Officer | 5 de diciembre de 2023 A | 50 000 | 0 | 0 | $0 |
| Hamed Alavi | Chief Technology Officer | 16 de diciembre de 2025 J | 0 | 0 | 0 | $0 |
| Marc H. Glickman | SVP & Chief Medical Officer | 16 de diciembre de 2025 J | 101 600 | 0 | 0 | $0 |
| Benedict Broennimann | Chief Medical Officer, OUS | 27 de noviembre de 2018 A | 437 778 | 0 | 0 | $0 |
| Francis Duhay | Consejero | 11 de septiembre de 2026 S | 2 351 | 0 | 4 | $-4 942 |
| Robert Gray | Consejero | 11 de diciembre de 2025 A | 11 155 | 0 | 0 | $0 |
| Sanjay Shrivastava | Consejero | 11 de diciembre de 2025 A | 9 288 | 0 | 0 | $0 |
| Matthew Jenusaitis | Consejero | 11 de diciembre de 2025 A | 16 545 | 0 | 0 | $0 |
| Marcus W. Robins | Consejero | 27 de noviembre de 2018 A | 29 183 | 0 | 0 | $0 |
| Biodyne Holding, S.A. | · | 21 de agosto de 2020 S | 1 405 433 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 1 ETF
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 6 287 SH | 19 de agosto de 2026 | Diario |
NVNO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 7 analistas
COMPRA
Objetivo mediano
$30.00
+351,1%
3 42,9%
Compra fuerte
3 42,9%
Compra
1 14,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
1 analistas · 2026-10-25Objetivo medio $30.00 +351,1%
Mín$30.00
Media$30.00
Máx$30.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Jul 30, 2026